Oncology
Tartu University Hospital is involved in clinical research on advanced prostate cancer and glioblastoma multiforme, with studies focused on treatment-resistant disease, tumour control, and survival outcomes.
- Castration-resistant prostate cancer
- Taxane-resistant disease
- Glioblastoma multiforme
The oncology portfolio includes interest in combined systemic therapy, precision radiotherapy, and treatment strategies used alongside standard neuro-oncology care.
Ear, Nose and Throat Disorders
Clinical activity includes research in chronic rhinosinusitis with nasal polyps, particularly non-type 2 disease, with attention to symptom burden, nasal polyp control, and upper airway inflammation.
- Chronic rhinosinusitis with nasal polyps
- Non-type 2 inflammatory disease
- Sinonasal symptom assessment
This area reflects therapeutic interest in biologic treatment approaches for persistent sinonasal disease and related quality-of-life impairment.
Musculoskeletal and Joint Disease
The sponsor supports research in temporomandibular joint osteoarthritis, with emphasis on degenerative joint change, pain-related symptoms, and functional limitation in advanced TMJ disease.
- Temporomandibular joint osteoarthritis
- Wilkes class 4-5 disease
- Degenerative joint repair
Interest in this field includes regenerative and structural approaches for joint degeneration and restoration of mandibular function.
Infectious Diseases and Antimicrobial Therapy
Tartu University Hospital is also active in research on serious infections requiring intravenous vancomycin, with a focus on treatment exposure, antimicrobial management, and critically ill adult patients.
- Serious bacterial infections
- Intravenous vancomycin therapy
- Model-informed precision dosing
This research area centres on optimizing anti-infective therapy in hospital care settings where drug exposure is closely linked to clinical response.
